SUPERBUNDLE

Serial Number 87030980
606

Registration Progress

Application Filed
May 10, 2016
Under Examination
Apr 25, 2017
Approved for Publication
Feb 28, 2017
Published for Opposition
Feb 28, 2017
Registered

Trademark Image

SUPERBUNDLE

Basic Information

Serial Number
87030980
Filing Date
May 10, 2016
Published for Opposition
February 28, 2017
Abandonment Date
June 8, 2020
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 8, 2020
Classes
005

Rights Holder

HARROW IP, LLC

16
Address
102 WOODMONT BLVD., SUITE 610
NASHVILLE, TN 37205

Ownership History

IMPRIMIS PHARMACEUTICALS, INC.

Original Applicant
03
San Diego, CA

IMPRIMIS PHARMACEUTICALS, INC.

Owner at Publication
03
San Diego, CA

HARROW HEALTH, INC.

New Owner After Publication #1
03
SAN DIEGO, CA

HARROW IP, LLC

New Owner After Publication #2
16
NASHVILLE, TN

Legal Representation

Attorney
Antony M. Novom

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description Documents
Jun 8, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 8, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 6, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 22, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 21, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 21, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 16, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 13, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 11, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 11, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 11, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 16, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 16, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 12, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 12, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 12, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 14, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 12, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 12, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 12, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 18, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 16, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 16, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 16, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 25, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 28, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 28, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 22, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 8, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 24, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 24, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 24, 2017 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jan 24, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 24, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 20, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 19, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 19, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 21, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 21, 2016 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 21, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 20, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
May 14, 2016 MPMK E NOTICE OF PSEUDO MARK E-MAILED Loading...
May 13, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Medical kits comprising compounded pharmaceutical formulations for ocular treatments, and vials, syringes, needles and/or droppers for administering the compounded formulations to patients prior to, during, or following an ophthalmological procedure

Additional Information

Pseudo Mark
SUPER BUNDLE

Classification

International Classes
005